Mounjaro (tirzepatide) is a popularly prescribed weekly injectable medicine used for Type 2 diabetes
Patients were randomized to receive one of six ordered sequences of the three treatment pathways: amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin, each pathway lasting 16 weeks
[DOI] [PubMed] [Google Scholar] 24.Clausen AE, Kast CE, Bernkop-Schnrch A
And I think the big question is to determine whether improvements in disease activity that we might see, whether they're entirely due to weight loss, or are there actually direct anti-inflammatory effects of these medications, which could be really interesting
( 3.4 Tryptophan metabolism disruption Recent studies have highlighted the role of tryptophan metabolism disruption in promoting atherosclerosis
Tirzepatide, acting on both GIP and GLP-1 receptors, is effective in reducing weight and controlling glucose, providing superior weight loss effects